Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(0.25) per share from the same period last year.
Would You Sell Your House For Tesla Stock? This Guy Did And Here’s How Much He Made
Last year marked Tesla Inc's (NASDAQ: TSLA) worst stock performance since going public, with shares down over 60% in 2022.